Metabolic Syndrome Increases All-Cause and Vascular Mortality: The Hong Kong Cardiovascular Risk Factor Study

Clinical Endocrinology - United Kingdom
doi 10.1111/j.1365-2265.2007.02798.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Development and Validation of an All-Cause Mortality Risk Score in Type 2 DiabetesThe Hong Kong Diabetes Registry

Archives of Internal Medicine
2008English

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Cardiovascular Risk Factors and 10-Year All-Cause Mortality in Elderly European Male Populations. The FINE Study

European Heart Journal
Cardiovascular MedicineCardiology
2001English

C-Reactive Protein as a Predictor of Hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study (CRISPS) Cohort

Journal of Human Hypertension
Internal Medicine
2011English

Television Viewing and Risk of Type 2 Diabetes, Cardiovascular Disease, and All-Cause Mortality

JAMA - Journal of the American Medical Association
Medicine
2011English

Association of Peripheral Arterial Disease With All-Cause Mortality, Cardiovascular Mortality and Cardiovascular Events

Angiology: Open Access
2013English

Metabolic Syndrome: Risk Factor Distribution and 18-Year Mortality in the Multiple Risk Factor Intervention Trial

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

A Comparison of Components of Two Definitions of the Metabolic Syndrome Related to Cardiovascular Disease and All-Cause Mortality in a Cohort Study in Thailand

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2007English

Disruption of Circadian Rhythm Increases the Risk of Cancer, Metabolic Syndrome and Cardiovascular Disease

Journal of Local and Global Health Science
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy